Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Third-hand smoke as deadly as first-hand smoke

Do not smoke and do not allow yourself to be exposed to smoke because second-hand smoke and third-hand smoke are just as deadly as first-hand smoke, says a scientist at the University of California, Riverside who, along with colleagues, conducted the first animal study of the effects of third-hand smoke.

30 Jan 2014

Viewpoints: Consumers awakening to health law's 'perverse incentives;' Medicaid expansion could help Dems in mid-term elections; new 'devious tactic' in smoking

With fewer glitches to deter them, millions of Americans are now logging on to the ObamaCare health-insurance-exchange websites. When they get there, many are discovering some unpleasant surprises:

25 Jan 2014

Prosonix announces positive top-line results from PSX1002 Phase 2 study for COPD treatment

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive pulmonary disease.

23 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

IQWiG publishes new clinical practice guidelines for treating people with COPD

On 3 January 2014 the German Institute for Quality and Efficiency in Health Care published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with chronic obstructive pulmonary disease.

9 Jan 2014

Ihealth unveils new wearable personal health devices at CES 2014

Today, iHealth Lab Inc., announced the extension of its suite of personal mobile health devices to include a line of wearable products designed to provide monitoring over an extended period of time.

7 Jan 2014

Study indicates that smoking disrupts circadian clock function in both lungs and brain

As if cancer, heart disease and other diseases were not enough motivation to make quitting smoking your New Year's resolution, here's another wake-up call: New research published in the January 2014 issue of The FASEB Journal suggests that smoking disrupts the circadian clock function in both the lungs and the brain.

3 Jan 2014

Scientists discover new class of cells expressing olfactory receptors in human airways

Your nose is not the only organ in your body that can sense cigarette smoke wafting through the air. Scientists at Washington University in St. Louis and the University of Iowa have showed that your lungs have odor receptors as well.

3 Jan 2014

Electromed gets FDA clearance to market next generation SmartVest Airway Clearance System

Electromed, Inc., a global medical device company, today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL has been cleared to market.

30 Dec 2013

Poverty, not smoking, linked to COPD mortality

An international study shows that national mortality rates for chronic obstructive pulmonary disease do not correlate well with the prevalence of smoking in low-income countries but do show a strong inverse correlation with wealth.

30 Dec 2013

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders have reached a definitive agreement to sell the Commercial Business to Madison Dearborn Partners in a transaction valued at approximately $1.6 billion.

26 Dec 2013

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Researchers cite identification and monitoring of known underlying chronic medical conditions as opportunities to reduce readmission rates and improve patient safety.

24 Dec 2013

Cycle test reliable for dyspnea evaluation in obese COPD patients

Dyspnea in obese individuals with chronic obstructive pulmonary disease can be evaluated reliably by cycle ergometry as well as a treadmill test, researchers have found.

20 Dec 2013

New antibody could boost strength, muscle mass in patients with cancer and other diseases

A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.

20 Dec 2013

COPD undertreatment widespread

A study has shown that undertreatment of chronic obstructive pulmonary disease is highly prevalent.

19 Dec 2013

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Mylan Inc. today announced that it has received all regulatory approvals and has completed an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize a novel long-acting muscarinic antagonist compound for various indications.

18 Dec 2013

Cardiovascular disease in asthma needs attention

Researchers say that there should be a greater emphasis on preventing cardiovascular disease in people with asthma after finding that it was the leading cause of death in hospitalized asthma patients.

17 Dec 2013

New report shows death rates for lung cancer dropping at a faster pace

The Annual Report to the Nation on the Status of Cancer, covering the period 1975, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. The recent larger drop in lung cancer deaths is likely the result of decreased cigarette smoking prevalence over many years, and is now being reflected in mortality trends. The lung cancer death rate decline, as well as declines in colorectal, breast, and prostate cancer death rates, has also helped drive decreases in death rates for all cancers types combined, a trend that began about 20 years ago.

17 Dec 2013

Airway alterations present even in young smokers without COPD

A study has found functional and inflammatory changes in the nasal and lower airways of young, healthy smokers in the absence of pulmonary function decline.

12 Dec 2013

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

MedImmune, AstraZeneca’s global biologics research and development arm, and The Johns Hopkins University today announced they have entered into a five-year, $6.5 million research collaboration.

12 Dec 2013

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Third-hand smoke as deadly as first-hand smoke

Viewpoints: Consumers awakening to health law's 'perverse incentives;' Medicaid expansion could help Dems in mid-term elections; new 'devious tactic' in smoking

Prosonix announces positive top-line results from PSX1002 Phase 2 study for COPD treatment

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

IQWiG publishes new clinical practice guidelines for treating people with COPD

Ihealth unveils new wearable personal health devices at CES 2014

Study indicates that smoking disrupts circadian clock function in both lungs and brain

Scientists discover new class of cells expressing olfactory receptors in human airways

Electromed gets FDA clearance to market next generation SmartVest Airway Clearance System

Poverty, not smoking, linked to COPD mortality

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Cycle test reliable for dyspnea evaluation in obese COPD patients

New antibody could boost strength, muscle mass in patients with cancer and other diseases

COPD undertreatment widespread

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Cardiovascular disease in asthma needs attention

New report shows death rates for lung cancer dropping at a faster pace

Airway alterations present even in young smokers without COPD

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in